Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-04-20 Sale |
2022-04-22 6:47 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
50,000 | $114.71 | $5,735,449 | 176,935 (Indirect Direct) |
View |
| 2022-04-06 Sale |
2022-04-08 4:09 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
307,045 | $110.01 | $33,777,814 | 226,935 (Indirect Direct) |
View |
| 2022-03-23 Sale |
2022-03-25 6:38 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
39,933 | $110.01 | $4,392,859 | 189,707 (Indirect Direct) |
View |
| 2021-12-28 Sale |
2021-12-30 9:00 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
8,575 | $110 | $943,250 | 235,803 (Indirect Direct) |
View |
| 2021-05-14 Sale |
2021-05-14 6:12 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
102,925 | $90.01 | $9,263,847 | 174,588 (Indirect Direct) |
View |
| 2020-08-24 Sale |
2020-08-25 5:16 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
29,576 | $75.76 | $2,240,702 | 103,974 (Indirect Direct) |
View |
| 2020-05-05 Sale |
2020-05-07 4:27 pm |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
104,994 | $38 | $3,989,772 | 132,501 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-05 Option Award |
2024-06-07 4:05 pm |
N/A 2034-06-04 |
Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director |
9,279 | $0 | 9,279 (Direct) |
View |
| 2024-04-01 Option Award |
2024-04-03 8:17 pm |
N/A 2034-03-31 |
Sagimet Biosciences Inc. | SGMT | Hoelscher Paul W. Director |
73,014 | $0 | 73,014 (Direct) |
View |
| 2023-06-06 Option Award |
2023-06-08 6:15 pm |
N/A 2033-06-05 |
Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director |
17,500 | $0 | 17,500 (Direct) |
View |
| 2022-06-01 Option Award |
2022-06-03 5:00 pm |
N/A 2032-05-31 |
Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director |
6,376 | $0 | 6,376 (Direct) |
View |
| 2022-04-20 Exercise |
2022-04-22 6:47 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
50,000 | $22.14 | 176,935 (Direct) |
View |
| 2022-04-20 Exercise |
2022-04-22 6:47 pm |
N/A 2025-03-22 |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
50,000 | $0 | 176,935 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 4:09 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
30,275 | $15.96 | 226,935 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 4:09 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
185,060 | $22.14 | 226,935 (Direct) |
View |
| 2022-04-06 Exercise |
2022-04-08 4:09 pm |
N/A 2024-06-26 |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
215,335 | $0 | 226,935 (Direct) |
View |
| 2022-03-23 Exercise |
2022-03-25 6:38 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
26,090 | $15.96 | 189,707 (Direct) |
View |
| 2022-03-23 Exercise |
2022-03-25 6:38 pm |
N/A 2024-06-26 |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
26,090 | $0 | 189,707 (Direct) |
View |
| 2022-03-07 Gift |
2022-03-25 6:38 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
238,852 | $0 | 189,707 (Direct) |
View |
| 2022-01-21 Tax Withholding |
2022-01-24 5:06 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
2,463 | $86.42 | 246,064 (Direct) |
View |
| 2022-01-21 Exercise |
2022-01-24 5:06 pm |
2022-01-21 2022-01-21 |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
5,558 | $0 | 246,064 (Direct) |
View |
| 2022-01-20 Option Award |
2022-01-24 4:58 pm |
N/A 2032-01-19 |
Reneo Pharmaceuticals Inc. | RPHM | Hoelscher Paul W. Director |
35,000 | $0 | 35,000 (Direct) |
View |
| 2022-01-05 Tax Withholding |
2022-01-06 8:58 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
50,666 | $101.84 | 307,610 (Direct) |
View |
| 2022-01-05 Exercise |
2022-01-06 8:58 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
133,644 | $0 | 307,610 (Direct) |
View |
| 2022-01-04 Option Award |
2022-01-06 8:58 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
56,897 | $0 | 307,610 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 9:00 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
8,575 | $15.96 | 235,803 (Direct) |
View |
| 2021-12-28 Exercise |
2021-12-30 9:00 pm |
N/A 2024-06-26 |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
8,575 | $0 | 235,803 (Direct) |
View |
| 2021-08-25 Gift |
2021-12-30 9:00 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
7,212 | $0 | 235,803 (Direct) |
View |
| 2021-07-28 Tax Withholding |
2021-07-30 4:25 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
3,858 | $102.5 | 197,905 (Direct) |
View |
| 2021-07-28 Option Award |
2021-07-30 4:25 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
26,126 | $0 | 197,905 (Direct) |
View |
| 2021-02-01 Gift |
2021-02-19 5:00 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
3,094 | $0 | 299,647 (Direct) |
View |
| 2021-02-17 Option Award |
2021-02-19 5:00 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
24,492 | $0 | 299,647 (Direct) |
View |
| 2021-02-17 Tax Withholding |
2021-02-19 5:00 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
1,045 | $87.17 | 299,647 (Direct) |
View |
| 2021-01-21 Tax Withholding |
2021-01-22 9:01 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
2,462 | $77.43 | 281,758 (Direct) |
View |
| 2021-01-21 Exercise |
2021-01-22 9:01 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
5,556 | $0 | 281,758 (Direct) |
View |
| 2021-01-19 Gift |
2021-01-22 9:01 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
169,132 | $0 | 281,758 (Direct) |
View |
| 2021-01-05 Tax Withholding |
2021-01-06 9:05 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
134,698 | $73.28 | 355,045 (Direct) |
View |
| 2021-01-05 Exercise |
2021-01-06 9:05 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
196,384 | $0 | 355,045 (Direct) |
View |
| 2021-01-04 Option Award |
2021-01-06 9:05 pm |
N/A N/A |
Horizon Therapeutics Public Ltd Co | HZNP | Hoelscher Paul W. EVP, CFO |
240,566 | $0 | 355,045 (Direct) |
View |